In outpatients with COVID-19 during Omicron variant circulation, molnupiravir and nirmatrelvir-ritonavir improved outcomes.
Where this comes from
- Record sourced from PubMed, PMID 38163374.
- Also identified by DOI 10.7326/J23-0108.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Sommer I, Ledinger D, Thaler K, et al. <b>Outpatient treatment of confirmed COVID-19: a living, rapid evidence review for the American College of Physicians (version 2).</b> Ann Intern Med. 2023;176:1377-1385. 37722115.